MarketInOut Stock Screener Log In | Sign Up

Suven Life Sciences Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:50
Suven Life Sciences Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization60,725 mln
Float97.26 mln

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

0.31
Highly suspicious

Relative Strength

26 / 100
Underperforming

Debt / Equity

0.03
Debt-free

Pre-Tax Margin

-3,999%
Severely loss-making

ROE

-108
Deeply negative

Business Description

Suven Life Sciences Limited is a clinical-stage biopharmaceutical company headquartered in Hyderabad, India, focused on developing new medicines for brain-related conditions such as Alzheimer's disease, depression, and sleep and cognitive disorders. The company has several drug candidates at various stages of development targeting the central nervous system, along with one candidate aimed at gastrointestinal conditions. Founded in 1989 and operating across India, the United States, Europe, and other markets, Suven Life Sciences functions as a subsidiary of Jasti Property and Equity Holdings Private Limited.

Key Fundamentals

EPS-12.31
ROE-108
RPS0.32
ROIC-388
ROA-96.40
Interest Cover-588
EBITDA, mln-3,454
EV / EBITDA-25.16
EV / EBIT-24.70
Revenue, mln88.14
EV / Revenue986

Quote Details

Last 261.35
Change 0.25 (0.1%)
Open 262.10
Volume 11,283
Turnover 2,948,812
Average Volume 44,892

Financial Ratios

Pre-Tax Profit Margin-3,999
Leverage Ratio1.06
Current Ratio29.16
Price / Book14.27
Price / Tangible Book14.27
Debt / Equity0.03
Price / Sales920

Financial Strength

Altman Z-Score165
Piotroski F-Score 2 / 9
Beneish M-Score0.31

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -10.19% 12 / 100   
1 Month -21.63% 6 / 100   
2 Months -22.86% 15 / 100   
6 Months 30.35% 86 / 100   
1 Year 31% 87 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog